Winette T.A. van der Graaf

Research interests

Publications

• ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe

  Annals of Oncology · 2022 · https://doi.org/10.1016/j.annonc.2022.07.1941

• Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.09.005

• Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts

  ESMO Open · 2021 · https://doi.org/10.1016/j.esmoop.2021.100170

• Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.07.006

• Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)

  ESMO Open · 2021 · https://doi.org/10.1016/j.esmoop.2021.100096

• Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.08.1995

• Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

  Cancer · 2021 · https://doi.org/10.1002/cncr.33618

• Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy310

• Corrections to “Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up”

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy321

• An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG)

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx323

• Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

  The Lancet Oncology · 2014 · 10.1016/s1470-2045(14)70063-4

• Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

  The Lancet · 2012 · 10.1016/s0140-6736(12)60651-5

• Mycobacterium ulcerans disease.

  PubMed · 2005 · https://doi.org/

Current projects

No projects listed.